Faculty Profiles - MORISE Masahiro

Papers - MORISE Masahiro

Division display 81 - 93 of about 93 ／ All the affair displays >>

The association of intravascular stromal cells with prognosis in high-grade neuroendocrine carcinoma of the lung Reviewed International journal

Sekihara K, Hishida T, Ikemura S, Saruwatari K, Morise M, Kuwata T, Fujii S, Kojima M, Ochiai A, Funai K, Aokage K, Yoshida J, Tsuboi M, Ishii G

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY Vol. 142 ( 5 ) page： 905-912 2016.5

Drastic morphological and molecular differences between lymph node micrometastatic tumors and macrometastatic tumors of lung adenocarcinoma Reviewed International journal

Aramaki N, Ishii G, Yamada E, Morise M, Aokage K, Kojima M, Hishida T, Yoshida J, Ikeda N, Tsuboi M, Ochiai A

Vol. 142 ( 1 ) page： 37-46 2016.1

Factors Affecting the Diagnostic Yield of Transbronchial Biopsy Using Endobronchial Ultrasonography with a Guide Sheath in Peripheral Lung Cancer Reviewed International journal

Okachi Shotaro, Imai Naoyuki, Imaizumi Kazuyoshi, Iwano Shingo, Ando Masahiko, Hase Tetsunari, Aso Hiromichi, Morise Masahiro, Wakahara Keiko, Ito Satoru, Hashimoto Naozumi, Sato Mitsuo, Kondo Masashi, Hasegawa Yoshinori

Internal Medicine Vol. 55 ( 13 ) page： 1705 - 1712 2016

Language：English Publishing type：Research paper (scientific journal) Publisher：The Japanese Society of Internal Medicine

Objective Endobronchial ultrasonography with a guide sheath (EBUS-GS) and virtual bronchoscopic navigation (VBN) improves the diagnostic yield in patients with peripheral pulmonary lesions (PPLs). Most previous reports on EBUS-GS-guided transbronchial biopsy (TBB) have included patients with benign and malignant diseases. We aimed to determine the factors that predicted a successful diagnosis by EBUS-GS-guided TBB diagnostic in patients with small peripheral lung cancer, with a focus on the high-resolution computed tomography (HRCT) findings before bronchoscopy. Methods We retrospectively reviewed the medical records of 173 consecutive patients with 175 small (≤30 mm) PPLs who were diagnosed with primary lung cancer between June 2010 and October 2013 at Nagoya University Hospital. All patients underwent EBUS-GS-guided TBB with VBN using a ZioStation computer workstation (Ziosoft, Osaka, Japan). We analyzed the patient characteristics, HRCT findings, diagnostic yield, and the diagnostic factors in small peripheral lung carcinoma. Results The EBUS probe position was within the PPL in 83 of the 175 lesions (47%) and 112 (64.0%) cases were successfully diagnosed by EBUS-GS-guided TBB. A univariate analysis revealed that the following factors were associated with a significantly higher diagnostic yield: CT bronchus sign positivity, a lesion of >20 mm in diameter, a solid nodule, and a probe position that was within the lesion. The following factors were not significant: the lesion location, the number of biopsies, and the lung cancer histology. A multivariate analysis revealed that the following factors significantly affected the diagnostic yield: CT bronchus sign positivity [odds ratio (OR) =2.479]; a probe position that was within the lesion (OR=2.542); and a solid nodule (OR=2.304). Conclusion The significant factors that were significantly associated with a successful diagnosis using EBUS-GS-guided TBB in small peripheral lung carcinoma were as follows: CT bronchus sign positivity, a solid nodule, and a probe position that was within the lesion.

DOI： 10.2169/internalmedicine.55.6341

Web of Science

PubMed

CiNii Research

Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung Reviewed

Udagawa H, Ishii G, Morise M, Umemura S, Matsumoto S, Yoh K, Niho S, Ohmatsu H, Tsuboi M, Goto K, Ochiai A, Ohe Y

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY Vol. 141 ( 8 ) page： 1417-25. 2015.8

Presence of podoplanin-positive cancer-associated fibroblasts in surgically resected primary lung adenocarcinoma predicts a shorter progression-free survival period in patients with recurrences who received platinum-based chemotherapy Reviewed International journal

Koriyama H, Ishii G, Yoh K, Neri S, Morise M, Umemura S, Matsumoto S, Niho S, Ohmatsu H, Tsuboi M, Goto K, Ochiai A

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY Vol. 141 ( 7 ) page： 1163-70 2015.8

Environmental Factors of Thoracic Malignancies Invited

Vol. 62 ( 10 ) page： 963 - 968 2014.10

Low-dose Irinotecan as a Second-line Chemotherapy for Recurrent Small Cell Lung Cancer Reviewed International journal

Morise M, Niho S, Umemura S, Matsumoto S, Yoh K, Goto K, Ohmatsu H, Ohe Y

JAPANESE JOURNAL OF CLINICAL ONCOLOGY Vol. 44 ( 9 ) page： 846-51 2014.9

最新がん薬物療法学　小細胞肺癌 Invited

森瀬昌宏, 後藤功一

日本臨床増刊号 Vol. 72 ( 2 ) page： 346-349 2014

講座　肺癌化学療法の最前線　小細胞肺癌に対する化学療法 Invited

森瀬昌宏, 後藤功一

呼吸 Vol. 32 ( 7 ) page： 631-637 2013.7

特集　オンコロジーエマージェンシーと支持療法の進歩　抗がん剤による過敏反応，インフュージョンリアクション Invited

森瀬昌宏, 後藤功一

呼吸器内科 Vol. 23 page： 261-267 2013.3

Dual pathway activated by tert-butyl hydroperoxide in human airway anion secretion Reviewed International journal

Matsuno T, Ito Y, Ohashi T, Morise M, Takeda N, Shimokata K, Imaizumi K, Kume H, Hasegawa Y

THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPUTICS Vol. 327 ( 2 ) page： 453-64 2008.11

肺病変を伴ったmulticentiric Castleman’s diseaseの一例 Reviewed

森瀬昌宏, 下元博史, 本多豊大, 森良雄

日本呼吸器学会誌 Vol. 41 page： 59-65 2003.1

胸壁原発悪性線維性組織球腫の1例 Reviewed

下元博史, 森瀬昌宏, 佐藤榮作, 山内晶司

日本胸部臨床 Vol. 62 ( 6 ) page： 561 -566 2003

　 PREV - NEXT 　

<MORISE Masahiro>

Papers - MORISE Masahiro